716 AURELIO-04: a phase 2, open-label, single-arm, multicenter study to determine the efficacy and safety of SOT101 in combination with pembrolizumab in patients with selected advanced solid tumors

Regular and Young Investigator Award Abstracts(2022)

引用 0|浏览4
暂无评分
关键词
pembrolizumab,advanced solid tumors,sot101,open-label,single-arm
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要